Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Phase II study of oral masitinib mesilate in imatinib-naïve patients with locally advanced or metastatic gastro-intestinal stromal tumour (GIST).
FOCIS 2014: Spotlight on Translational Immunology
Episode 58 with Dr. Gavin Giovannoni on the new MS Brain Health initiative
HLA-DRB1*15:01 and multiple sclerosis: a female association?
12th International Society of Neuroimmunology Congress
Summit 2013 + Expo
EAE: an immunologist's magic eye.
No evidence of disease activity: indirect comparisons of oral therapies for the treatment of relapsing-remitting multiple sclerosis.
Cost analysis of glatiramer acetate versus interferon-β for relapsing-remitting multiple sclerosis in patients with spasticity: the Escala study.
Scientific discussion for the approval of Masivet
Recruiting women smokers: the engineering of consent.
Sex ratio of multiple sclerosis and clinical phenotype.
BG 12: BG 00012, BG 12/Oral Fumarate, FAG-201, second-generation fumarate derivative--Fumapharm/Biogen Idec.
Mycophenolate mofetil therapy in the management of inflammatory bowel disease - A retrospective case series and review.
Genetics and the environment converge to dysregulate N-glycosylation in multiple sclerosis.
Neurodegeneration: From Multiple Sclerosis to Alzheimer’s Disease
Temporal trends in the incidence of multiple sclerosis: a systematic review.
Episode 54 with Dr. Jonathan Kipnis: Part 2 on meningeal lymphatic vessels in neuroinflammation, and clinical implications
Early magnetic resonance imaging predictors of clinical progression after 48 months in clinically isolated syndrome patients treated with intramuscular interferon β-1a.
Gas6 deficiency increases oligodendrocyte loss and microglial activation in response to cuprizone-induced demyelination.
Episode 37 with Dr. Jeanne Loring on human pluripotent stem cells in a mouse model of MS
[Recommendations for a brief international cognitive assessment for multiple sclerosis].
Episode 49 with Dr. Hugh Rosen on sphingosine 1-phosphate receptor modulators
ECTRIMS 2015
T(H)17 cytokines in autoimmune neuro-inflammation.

Pages